The Global “Schisandra Market” is estimated to reach a high CAGR of 7.56% during the forecast period (2021-2028).
Schisandra (Schisandra Chinensis) is a plant whose deep red berries have long been used in traditional Chinese medicine. Schisandra is classified as an “adaptogen” in traditional Chinese medicine, which refers to a plant or herb that helps the body maintain homeostasis by balancing its functions. Since it contains all five of the essential flavors of Chinese herbal medicine, the berry is sometimes referred to as the “five-flavor berry”: sweet, salty, spicy, sour, and bitter. Since it has these flavors, it can benefit all five yin organs: the lungs, liver, heart, kidneys, and spleen. Schisandra berries also provide powerful antioxidant protection, particularly from free radicals and other toxins in the environment that may cause cellular damage. In Traditional Chinese Medicine (TCM), Schisandra is considered to have anti-aging properties as well as the ability to enhance physical, mental, and sexual endurance. The seeds of berries can be used to treat a number of illnesses, including asthma, cough, indigestion, diarrhea, flu, insomnia, skin allergies, heart palpitations, insulin resistance, and premenstrual syndrome. Due to its various advantages, the market for Schisandra is expected to grow with a CAGR of 7.56% during the forecast period.
Download free sample: https://www.datamintelligence.com/download-sample/schisandra-market
Various health benefits of Schisandra is expected to drive the market growth
Schisandra is used to treat a variety of health problems. Schisandra can have a beneficial impact on a number of conditions and diseases, according to scientific evidence from animal and human studies. For instance, a 2017 study Trusted Source found that Schisandrin B had a beneficial, positive effect on Alzheimer’s disease. Researchers discovered that the positive effect was caused by Schisandrin B’s ability to block the formation of excess amyloid-beta peptides in the brain. These peptides are one of the components that contribute to the formation of amyloid plaque, a material contained in Alzheimer’s patients’ brains. According to another study, Schisandrin B could be useful in the treatment of both Alzheimer’s and Parkinson’s disease. This is because it has an anti-inflammatory and neuroprotective effect on brain microglial cells. The effects of Schisandra extract on women suffering from menopausal symptoms were investigated in a 2016 study. For a year, 36 menopausal women were followed. Researchers discovered that Schisandra can help alleviate some of the symptoms of menopause. Schisandra also has adaptogenic properties which help the body resist the effects of anxiety and stress, plus bolster the body’s defenses against stress. Additionally, schisandra offers great benefits for athletes.
By Distribution Channel
The Asia Pacific is expected to dominate the global Schisandra market
The Asia Pacific region accounted for the largest share of the regional Schisandra market. China dominated the Asia Pacific Schisandra market with a share of XX% in the year 2020. In China, it is popular to include medicinal plants of various kinds in foods to improve their overall health value. Schisandra is widely used in food and beverage applications. According to the Chinese, drinking Schisandra berry tea for one hundred days will repair health completely. Drinking Schinsadnra berry tea every day, at least twice a day, can help lose at least two pounds a week. Infusing Schisandra berries with dark cherry juice is one way to achieve the weight-loss benefits of doing so on a daily basis. Cherry juice is also a blood and liver fortifier that has been related to weight loss through metabolism control. The anti-inflammatory properties of the Schisandra berries can be improved by Vitamin C in dark cherry juice. Moreover, the presence of key players in China is expected to drive the China Schisandra market from USD XX thousand in 2020, to USD XX thousand in 2028, growing with a CAGR of 8.41% during the forecast period. Hunan Nuoz Biological Technology Co., Ltd, Shaanxi Fuheng (FH) Biotechnology Co., Ltd, Suzhou Vitajoy Bio-Tech. Ltd and Xi’an SR Bio-Engineering Co., Ltd. are some of the key players in the China Schisandra market.
The global Schisandra extract market is fragmented, with a large number of small players operating in the market. As the production of Schisandra is highly consolidated in a few countries such as China, South Korea, Japan and Russia, extract producing companies are also bound to these regions. Most of the major companies are operating in China with limited direct sales in global markets. The distribution of Schisandra extract in other countries is covered by local herbs, herbal extracts and phytochemical suppliers. Hunan Nuoz Biological Technology Co., Ltd, Suzhou Vitajoy Bio-Tech. Ltd, Shanghai Freemen, Shaanxi Fuheng (FH) Biotechnology Co., Ltd and Greenutra Resource Inc. are some of the key players operating the market. Most of these companies are framing agreements with herbal medicine, supplements, food and cosmetic manufacturers for the supply of their Schisandra extract as an ingredient. Furthermore, these companies are focused on the integration of the value chain by entering in to supplement or other end-use formulations, thereby gaining a wide customer base and business margins
COVID-19 Impact: The market revenue for global Schisandra to shoot up to USD XX thousand in 2020 from nearly USD XX thousand in 2019, due to the pandemic
Herbal ingredients made from wild plants in Traditional Chinese Medicine (TCM) and other herbal-based products around the world are expected to rise dramatically as a result of the COVID-19 outbreak. Plants account for roughly 80% of TCM products in China. Wild plant species account for approximately 30% of TCM industrial production volume, accounting for 70% of the species. The TCM industry’s resource base is made up of supply chains from China and around the world. COVID-19 patients in China are treated with a mixture of TCM and Western treatments, with official COVID-19 drug variants provided by the National Health Commission of the People’s Republic of China. A study that screened 125 Chinese herbal medicines with the potential to directly inhibit COVID-19, as well as an analysis of historical records and human proof of SARS and H1N1 influenza prevention, are examples of research into the effectiveness of herbal treatments for COVID-19. Dried Schisandra berries, is one of the most frequently used plant species for SARS treatment.
View full report: https://www.datamintelligence.com/research-report/schisandra-market